Research Site

Bochum, North Rhine-Westphalia 44892

2 studies enrolling now · 8 studies all time

What they study most

Depression, Depressive Disorder, Depressive Disorder, Major, Hepatobiliary Cancers, Hypophosphatasia (HPP), Mental Disorders, Mood Disorders, Multiple Sclerosis, Parkinson's Disease, Relapsing Remitting Multiple Sclerosis

Studies at this site

• Observational Study Protocol: LIVER-R — Recruiting now
• Registry of Patients With Hypophosphatasia — Enrolling by invitation
• Dimethyl Fumarate (DMF) Observational Study — Completed
• Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS) — Stopped early
• Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease — Stopped early
• Observational Study to Characterize Real-world Clinical Outcomes With Relapsing-remitting Multiple Sclerosis (RRMS) — Completed
• Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial) — Completed
• Treatment Interruption of Natalizumab — Completed